← Back to headlines
Cantor Fitzgerald Reiterates Overweight Rating on Gilead Sciences
Cantor Fitzgerald has reiterated its Overweight rating on Gilead Sciences (GILD) following positive results from its HIV trial.
26 Jun, 11:11 — 26 Jun, 11:11
Sources
Showing 1 of 1 sources



